Brief: Nanexa Says Approval Of Clinical Trial Application For Nex-22 Study Delayed
April 16 (Reuters) - Nanexa AB NANEXA.ST :
* APPROVAL OF CLINICAL TRIAL APPLICATION FOR NEX-22 STUDY
DELAYED
Source text for Eikon: ID:nMFN9qMpDq
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))